-
Targeted sequencing CYLD cutaneous syndrome
Study
EGAS00001003840
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Colorectal
Study
EGAS00001003774
-
GBM cancer stem cell lines -RNA-seq and WGS data
Study
EGAS00001003700
-
WES of 2 human osteosarcoma and corresponding cell lines
Study
EGAS00001003923
-
Ewing's sarcoma sequencing data
Study
EGAS00001005689
-
Tracking the evolution of Therapy-Related Myeloid Neoplasms using chemotherapy signatures
Study
EGAS00001006903
-
Molecular and Clonal Evolution in Recurrent Metastatic Gliosarcoma
Study
EGAS00001004076
-
H3K27me3-mediated epigenetic repression regulates neuroblastoma development and contributes to biological heterogeneity
Study
EGAS00001008225
-
Whole genome sequence and RNA-seq data from paired tumour and germline samples from mesothelioma patients.
Study
EGAS00001005196
-
Whole-genome landscape of adult T-cell leukemia/lymphoma
Study
EGAS00001005237
-
Mutational landscape of renal cell carcinoma with venous tumor thrombus
Study
EGAS00001001950
-
Successful BRAF/MEK-inhibition in a young patient with BRAF V600E-mutated extrapancreatic acinar cell carcinoma (HIPO-021)
Study
EGAS00001004282
-
Whole Genome sequencing of adult T-cell leukemia/lymphoma
Study
EGAS00001001210
-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Initial whole genome sequencing of plasma cell neoplasms in First Responders exposed to the World Trade Center attack of September 11, 2001
Study
EGAS00001004467
-
Targets of MEK inhibition in DIPG
Study
EGAS00001004495
-
DNA and RNA sequencing data from Ovarian Carcinosarcoma patients from the Glasgow Cohort.
Study
EGAS00001006605
-
Multiomic profiling of early-passage melanoma cell lines.
Study
EGAS00001004536
-
Single cell RNA sequencing of CD19 CAR T-cell infusion products
Study
EGAS00001004576
-
Melanoma_C32_ENU_resistance_to_Combination_Therapy
Study
EGAS00001001614
-
Primary Neuroblastoma Circle-seq
Study
EGAS00001004797
-
Mutational Landscape and Tumor Burden Assessed by Cell-Free DNA in Diffuse Large B-Cell Lymphoma: a Population-based Study
Study
EGAS00001004733
-
BAP1_sequence_of_uveal_melanoma_cell_lines
Study
EGAS00001001520
-
CASCADE metastatic melanoma study
Study
EGAS00001004950
-
Linked-read based analysis of Medulloblastomas
Study
EGAS00001007064
-
G-SAM: Transcriptional Evolution of Glioblastomas Treated With Standard of Care
Study
EGAS00001005436
-
Genome-wide DNA Methylation Analysis Reveals a Unique Methylation Pattern for Pleural Mesothelioma Compared to Healthy Pleura and Other Lung Diseases
Study
EGAS00001007783
-
Genetic analysis of HLA and immune escape genes in Diffuse Large B-cell Lymphoma
Study
EGAS00001005054
-
Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer
Study
EGAS00001005108
-
Targeted sequencing of follicular lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001005238
-
Combining a Universal Telomerase Based Cancer Vaccine with Ipilimumab in Patients with Metastatic Melanoma - Five-year Follow up of a Phase I/IIa Trial
Study
EGAS00001005253
-
Molecular characteristics in Burkitt lymphoma over age groups
Study
EGAS00001005270
-
RNA sequencing of chondrosarcoma
Study
EGAS00001004585
-
Pediatric tumor in a single child of three large nuclear families
Study
EGAS00001005321
-
Pediatric Papillary Thyroid Carcinoma Whole Exome Sequencing
Study
EGAS00001005187
-
RNA-seq of Glioblastoma stem cells
Study
EGAS00001003070
-
Neuroblastoma tumor heterogeneity and cell plasticity (from patients)
Study
EGAS00001005322
-
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
Study
EGAS00001005328
-
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
Study
EGAS00001000714
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.
Study
EGAS00001005437
-
Spatial concordance of DNA methylation classification in diffuse glioma
Study
EGAS00001005434
-
Dissecting the Spatial Heterogeneity of Single Circulating Tumor Cells in Hepatocellular Carcinoma
Study
EGAS00001005204
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__head___neck
Study
EGAS00001005450
-
Investigate the evolutionary trajectories during invasiveness acquisition in early lung adenocarcinoma
Study
EGAS00001004754
-
Whole genome sequencing of patients with or at risk for HCC
Study
EGAS00001007249
-
Integrated genomic analyses reveal molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Study
EGAS00001005503
-
Whole Tumor spatial heterogeneity in metastatic melanoma
Study
EGAS00001003292
-
Whole-exome sequencing of hepatocellular carcinoma biopsies (proteogenomic study)
Study
EGAS00001005073